Healthleap discloses $30m Series A for clinical screening AI
The Series A forms part of $38m in combined financing announced by the company.
Hummingbird Ventures led the Series A, disclosed on October 7. The company’s wider financing announcement also included an earlier seed round.
Healthleap will expand the conditions its software screens for and hire across engineering, sales, customer success and product. The platform brings patient risk signals into hospital workflows so clinical teams can prioritise further assessment.
Use of funds
Expand condition coverage
Engineering, sales, customer success and product hiring